The use of alimentary tract and metabolism medicine in Sweden saw actual figures standing at 288 Units (Defined Daily Dosage) per Thousand Persons per Day for 2023. Forecasted data suggests a steady increase: 2024 to 2025 presents a 1.00% variation, followed by a 0.78% variation from 2025 to 2026. The increase continues with a 0.64% uptick from 2026 to 2027 and a modest 0.50% from 2027 to 2028. The compound annual growth rate (CAGR) over the next five years averages at approximately 0.80% per year.
Future trends to watch for include:
- Advancements in personalized medicine and biotechnology improving treatment efficacy for metabolic disorders.
- Increased emphasis on preventive healthcare potentially stabilizing or reducing the need for medication in the long term.
- Population aging and its contribution to rising demand for metabolism-related treatments.